Metagenomi, Inc.

NasdaqGS:MGX Stock Report

Market Cap: US$113.4m

Metagenomi Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:MGX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Dec 24SellUS$2,900Pamela WapnickIndividual1,559US$1.86
05 Sep 24SellUS$18,043Pamela WapnickIndividual6,265US$2.88
13 Feb 24BuyUS$12,000,000Novo Holdings A/SCompany800,000US$15.00
09 Feb 24BuyUS$1,025,000Novo Holdings A/SCompany100,000US$10.25

Insider Trading Volume

Insider Buying: MGX insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of MGX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies402,4961.08%
VC/PE Firms3,789,31810.1%
Individual Insiders4,089,62710.9%
Public Companies5,758,47015.4%
Institutions11,155,27329.8%
General Public12,228,73332.7%

Dilution of Shares: MGX only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 63.67% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.8%
Bayer Aktiengesellschaft
4,050,997US$12.3m0%no data
6.35%
Brian Thomas
2,377,284US$7.2m0%no data
5.07%
Humboldt Fund
1,896,445US$5.7m0%no data
5.06%
Sozo Ventures, LLC
1,892,873US$5.7m0%1.52%
4.81%
Novo Holdings A/S
1,800,000US$5.5m0%no data
4.56%
Moderna, Inc.
1,707,473US$5.2m0%no data
3.49%
RA Capital Management, L.P.
1,305,239US$4.0m-11.7%0.05%
2.82%
Farallon Capital Management, L.L.C.
1,057,201US$3.2m-21.3%0.02%
2.76%
PFM Health Sciences, LP
1,034,002US$3.1m-18.4%0.18%
2.15%
Citadel Advisors LLC
804,462US$2.4m10.2%no data
2.08%
Hillhouse Investment Management, Ltd.
777,768US$2.4m0%0.02%
2.06%
Sebastian Bernales
769,845US$2.3m0%no data
1.56%
Jian Irish
585,427US$1.8m0%no data
1.16%
BlackRock, Inc.
435,662US$1.3m3.67%no data
1.12%
Millennium Management LLC
417,878US$1.3m33.4%no data
1.08%
Praxis Biotech, LLC
402,496US$1.2m0%no data
1%
The Vanguard Group, Inc.
373,903US$1.1m73%no data
0.96%
Norges Bank Investment Management
360,202US$1.1m0%no data
0.9%
Geode Capital Management, LLC
338,031US$1.0m106%no data
0.82%
Deep Track Capital, LP
307,500US$931.7k-34%0.03%
0.75%
ExodusPoint Capital Management, LP
280,287US$849.3k45.4%0.01%
0.72%
Pura Vida Investments, LLC
270,618US$820.0k0%1.35%
0.62%
Kestra Advisory Services, LLC
230,305US$697.8k0%no data
0.49%
Renaissance Technologies LLC
182,100US$551.8k0%no data
0.45%
Marshall Wace LLP
168,639US$511.0k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/23 23:27
End of Day Share Price 2025/01/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Metagenomi, Inc. is covered by 7 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Konstantinos BiliourisBMO Capital Markets Equity Research
Yevgeniya LivshitsChardan Capital Markets, LLC
Mitchell KapoorH.C. Wainwright & Co.